Pfizer Inc. (PFE) To Pay $325 Million In Neurontin Settlement
6/3/2014 7:12:05 AM
Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses, its second settlement over the epilepsy drug in six weeks. The preliminary accord was disclosed on Friday in U.S. District Court in Boston. It resolves allegations in a decade-old civil lawsuit that Pfizer and its Warner-Lambert Co unit sold Neurontin for uses for which it was neither approved by the U.S. Food and Drug Administration nor medically effective, in an effort to boost profit.
Help employers find you! Check out all the jobs and post your resume.
comments powered by